Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma

Nobutaka Furuya(Dokkyo Medical University), Ken‐Ichiro Yoshida(Dokkyo Medical University)

Cancer Immunology Immunotherapy

February 24, 2011

10.1007/s00262-011-0989-3

Cited by 18

Related Papers

Higher preoperative serum levels of <scp>PD</scp>‐L1 and B7‐H4 are associated with invasive and metastatic potential and predictable for poor response to <scp>VEGF</scp>‐targeted therapy and unfavorable prognosis of renal cell carcinoma

|Cancer Medicine|2016|52

Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival

|Cancer Immunology Immunotherapy|2021|39

Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density

|Cancer Immunology Immunotherapy|2020|16

Axitinib for preoperative downstaging of renal cell carcinoma with sarcomatoid differentiation and direct invasion of the duodenum and inferior vena cava: a case report

|OncoTargets and Therapy|2014|8